medigraphic.com
ISSN 0188-2198 (Print)

2008, Number 1

<< Back Next >>

Rev Mex Cardiol 2008; 19 (1)

Cardiovascular risk factors in adult population of a Familiar Medical Unit of Meoqui, Chihuahua, Mexico

Contreras-Solís RE, Rendón-Aguilar P, Tufiño-Olivares ME, Levario-Carrillo M, Uranga-Urías TM

Language: Spanish
References: 29
Page: 7-15
PDF size: 134.16 Kb.


ABSTRACT

Background: Cardiovascular disease is a worldwide big public health problem. It represents the leading cause of death in men and women in Chihuahua. The objective of the study is to determine the prevalence of major cardiovascular risk factors in adult population in Meoqui, Chihuahua, Mexico. Methods: Descriptive study, that included 558 patients from a Medical Unity of the Social Security in this country, between 20 to 79 years old and whish completed the inclusion criteria. All of them signed the informed consent. We apply the inquiry, and measured arterial pressure, weight, height, and abdominal circumference. Eight hours fasten blood samples were taken for lipid profile and glucose determination and were processed in a SYNCHRON CX PRO. Results: Were 234 men and 324 women, with a median age of 44 ± 14 years old were analyzed. Hypertension was detected in 26%, pre-hypertension in 25%, diabetes mellitus 10%, obesity 42%, abdominal obesity 61%, smoking 24%, cholesterol level above 200 mg/dL 36%, hypertriglyceridaemia 41%, HDL below 40 mg/dL 42%, LDL above 100 mg/dL 65% and metabolic syndrome 28%. Conclusions: Almost all the risk factors were similar to other reports in our country, but obesity and abdominal obesity were more frequent and maybe its relation with metabolic syndrome could be the risk factors with major impact for coronary heart disease in this region.


REFERENCES

  1. St. Clair RW. Biología de la aterosclerosis. En: American Heart Association Eds. Compendio de cardiología preventiva (1). 1a ed. México: Grupo Mind; 1996: 11.

  2. Grupo Cooperativo del Consenso. Primer Consenso Mexicano sobre Síndromes Isquémicos Coronarios Agudos sin Elevación del Segmento ST. Arch Cardiol Mex 2002; 72(Supl 2): S5-S44.

  3. Grupo Cooperativo RENASICA. El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos. Arch Cardiol Mex 2002; 72(Supl 2): S45-S64.

  4. Arnett DK, Mc Govern PG, Jacobs DR y cols. Fifteen-years trends in cardiovascular risk factors (1980-1982 through 1995-1997) Estudio de Corazón de Minnesota. Am J Epidemiol 2002; 156: 929-935.

  5. Ilarraza H. Rehabilitación y prevención cardiovascular: El complemento necesario a la terapéutica de hoy. Arch Cardiol Mex 2003: 73: 247-252.

  6. Estadísticas de Mortalidad en México: Muertes registradas en el año 2001. Salud Publica Mex 2002; 44: S65-S81.

  7. Martínez J. Estratificación del riesgo coronario. Arch Cardiol Mex 2002; 72 (Supl 1): S130-S134.

  8. Blackburn H. El concepto de riesgo. En: American Heart Association Eds. Compendio de cardiología preventiva (1). 1ª ed. México: Grupo Mind; 1996: 11-53.

  9. Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF. Cardiovascular disease mortality en Hispanics and non-hispanics whites. Am J Epidemiol 2002; 156: 919-928.

  10. Grupo de Expertos en la detección, evaluación y tratamiento del colesterol sanguíneo elevado en adultos. Resumen ejecutivo del tercer reporte del grupo de expertos en la detección, evaluación y tratamiento del colesterol sanguíneo elevado en adultos, perteneciente al Programa Nacional de Educación Sobre el Colesterol (NCEP) Tercer Grupo de Tratamiento de Adultos (ATP III). JAMA 2001; 285: 2486-2497.

  11. Velázquez MO, Rosas PM, Lara A, Pastelín G. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de Salud (ENSA 2000). Arch de Cardiol Mex 2003; 73: 62-77

  12. Lara A, Rosas M, Pastelín G y cols. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004; 74: 231-245.

  13. Chobanian AV, Bakris GL, Black HR and the National high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003; 289: 2560-2572.

  14. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.

  15. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164: 2113-2118.

  16. Van den Hoogen PC, Feskens E, Nagelkerke N et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Country study Research Group. N Engl J Med 2000; 342: 1-8.

  17. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23(Suppl 1): S4-S19.

  18. Blümel JE, Castelo C, Rocangliolo ME, Binfa L, Sarra S. Factores de riesgo cardiovascular en una cohorte de mujeres de edad media. Rev Med Chile 2003; 131: 381-9.

  19. Ciriacos MC, Sisto A, Casuriaga AL, Paes C, Gonsalez C. Detección de factores de riesgo cardiovascular y oncológicos en una población de mujeres trabajadoras de Montevideo Uruguay. Arch Med Fam 2002; 4: 51-55.

  20. Fanghänel G, Sánchez L, Arellano S, Valdez E, Chavira J, Rascón RA. Prevalencia de factores de riesgo de enfermedad coronaria en trabajadores del Hospital General de México. Salud Publica Mex 1997; 39: 427-432.

  21. Ridker PM, Srampfer MJ, Rifai PM. Novel Risk Factors for Systemic Atherosclerosis. JAMA 2001; 285 : 2481-2486.

  22. Iso H, Jacobs DR. Serum colesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial (MRFIT). N Engl J Med 1989; 320: 904-910.

  23. Fernández H, Escobedo J, Hernández D. Consumo de tabaco en la población derechohabiente del Instituto Mexicano del Seguro Social. Salud Publica Mex 1997; 39: 125-132.

  24. Paniagua GL y cols. Factores de riesgo coronario en pacientes ambulatorios del Estado de México. Rev Med Hosp Gen Mex 2002; 65: 68-74.

  25. Terrés AM. El laboratorio clínico y la evaluación del riesgo coronario. Rev Mex Patol Clin 2000; 47: 202-18.

  26. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22.

  27. Pérez O. Lipoproteínas de alta densidad (HDL). ¿Un objetivo terapéutico en la prevención de la aterosclerosis? Arch Cardiol Mex 2004; 74: 53-67.

  28. González A, Lara A, Molina V, Velásquez O. Prevalencia del síndrome metabólico. En: González Chavez Antonio Ed. Síndrome metabólico y enfermedad cardiovascular. 1ª Ed. México: Intersistemas, 2004: 7-9.

  29. Meaney E, Vela A, Ramos A, Alemao E, Yin D. Cumplimiento de las metas con reductores del colesterol en pacientes mexicanos. El estudio COMETA México. Gac Med Mex 2004; 140: 493-501.




2020     |     www.medigraphic.com